Novo CEO pressed by Senate to chop price ranges of obesity, diabetic issues medications CEO Lars Fruergaard Jørgensen instructed lawmakers the company would take into account new talks with insurers concerning the list costs of Wegovy and copyright if they pledge to maintain the medicines on their formularies. This plan https://andrewnduj.thekatyblog.com/29774582/not-known-factual-statements-about-healthcare-news